Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors

Personalized cancer treatment depends on the accurate and timely detection of the patient tumor variants. LBx enables minimally invasive tumor mutation profiling. We report results of a pan-Canadian LBx program for patients with advanced solid tumors. Plasma samples were tested at Imagia Canexia Hea...

Полное описание

Библиографические подробности

Главные авторы:	Anna Lapuk, Benjamin L. S. Furman, Pedro Feijao, Ebru Baran, Sonal Brahmbhatt, Betty Chan, Ka Mun Nip, Adrian Kense, Brenda Murphy, Ruth Miller, Vincent Funari, Alicja Parker, Melissa K. McConechy, Shaqil Kassam, Arif A. Awan, Bryan Lo, Daniel Breadner, Barry D. Stein, David G. Huntsman
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2025-12-01
Серии:	Current Oncology
Предметы:	liquid biopsy NGS biomarkers precision oncology health economics
Online-ссылка:	https://www.mdpi.com/1718-7729/33/1/18
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!